AABH (aspartyl (asparaginyl) [beta]-hydroxylase) as a serum biomarker for colorectal cancer diagnosis and prognosis.

被引：0
|
作者：
Moshiri, Mahmood [1 ]
Moshiri, Arsha [1 ]
Moshiri, Kiarash [1 ]
机构：
[1] Next Pharma Inc, Richmond Hill, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Aspartyl (Asparaginyl) ß-Hydroxylase AABH as a serum biomarker for colorectal cancer.
    Moshiri, Mahmood
    Moshiri, Kiarash
    Farbod, Yasamin
    Moshiri, Arsha
    Sekhavati, Mohammad Hadi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [2] AABH (aspartyl [asparaginyl] β-hydroxylase) as a serum biomarker for breast cancer
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [3] Aspartyl (asparaginyl) β-hydroxylase (AABH), a serum biomarker for lung cancer
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [4] Colorectal cancer biomarker, AABH (Aspartyl [Asparaginyl] β- hydroxylase), a companion imaging and treatment strategy
    Moshiri, Mahmood
    Moshiri, Kiarash
    Nazari, Reza
    Pishrochi, Mohammad
    Moshiri, Arsha
    Monhemi, Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Early diagnosis of prostate cancer, AABH (Aspartyl Asparaginyl β-hydroxylase), a predictive biomarker: A serum immunoassay and personalized medicine
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Aspartyl (Asparaginyl) β-hydroxylase (AABH) as a serum biomarker for prostate cancer, to identify prostate cancer, regardless of PSA level.
    Moshiri, Mahmood
    Moshiri, Arsha
    Pashaei, Hamed
    Moshiri, Kiarash
    Nazari, Reza
    Monhemi, Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [7] Aspartyl (Asparaginyl) β hydroxylase (AABH) as a serum biomarker for prostate cancer to identify prostate cancer, regardless of PSA level.
    Moshiri, Mahmood
    Moshiri, Kiarash
    Moshiri, Arsha
    Monhemi, Hassan
    Sekhavati, Mohammad Hadi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Improved detection of cancer specific serum exosomal aspartyl (asparaginyl) beta hydroxylase (HAAH)
    Semenuk, Mark A.
    Cifuentes, Anokhi S.
    Ghanbari, Eleanor R.
    Lebowitz, Michael S.
    Ghanbari, Hossein A.
    CANCER RESEARCH, 2017, 77
  • [9] The aspartyl (asparaginyl) beta-hydroxylase in carcinomas
    Yang, Hui
    Li, Jing
    Tang, Ruihua
    Li, Ji
    Liu, Yaxiong
    Ye, Linjie
    Shao, Dongyan
    Jin, Mingliang
    Huang, Qingsheng
    Shi, Junling
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2015, 20 : 902 - 909
  • [10] Development of cancer immunodiagnostics using human aspartyl (asparaginyl) β-hydroxylase (HAAH) as a biomarker.
    Rosen, MA
    Ghanbari, K
    Deutch, AH
    Ghanbari, HA
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3785S - 3785S
12345